Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
13
Bearish filings
182
Named actors
24
Disclosed $ (bull / bear)
$17.0M / $85.7M
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-20 | 5%+ holder (13G) Pivotal bioVenture Partners Fund II, L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-08-18 | Activist (13D) — increased stake Catalyst4, Inc. | increased its stake (13D/G amendment) | — | SEC ↗ |
| 2026-08-03 | Activist (13D) — increased stake Catalyst4, Inc. | increased its stake (13D/G amendment) | — | SEC ↗ |
| 2026-08-03 | Chief Scientific Officer Lillie James Woodruff | sold | $277K | SEC ↗ |
| 2026-08-03 | Officer (via Jefferies LLC) Lillie James Woodruff | filed notice to sell | $288K |
170 more disclosures in the window — the full record, scoring, and validation are for members.
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-07-30 | Former Affiliate (via Morgan Stanley & Co. LLC) Novo Holdings A/S | filed notice to sell | $24.0M | SEC ↗ |
| 2026-07-28 | Director Cox Troy | bought | $149K | SEC ↗ |
| 2026-07-17 | Chief Executive Officer Kroeger Christopher A. | sold | $636K | SEC ↗ |
| 2026-07-17 | CAO and Interim CFO GILLIS JONATHAN | sold | $638K | SEC ↗ |
| 2026-07-17 | CAO and Interim CFO GILLIS JONATHAN | sold | $34K | SEC ↗ |
| 2026-07-17 | CAO and Interim CFO GILLIS JONATHAN | sold | $22K | SEC ↗ |
| 2026-07-17 | Chief Scientific Officer Lillie James Woodruff | sold | $79K | SEC ↗ |
| 2026-07-17 | General Counsel Hanson Kristopher | sold | $43K | SEC ↗ |
| 2026-07-17 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JONATHAN GILLIS | filed notice to sell | $687K | SEC ↗ |
| 2026-07-17 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) ANATOL KREITZER | filed notice to sell | $639K | SEC ↗ |
| 2026-07-17 | Chief Medical Officer Foff Erin Pennock | sold | $139K | SEC ↗ |
| 2026-07-17 | Chief Discovery Officer Kreitzer Anatol | sold | $105K | SEC ↗ |
| 2026-07-17 | Chief Discovery Officer Kreitzer Anatol | sold | $8K | SEC ↗ |
| 2026-07-17 | Chief Discovery Officer Kreitzer Anatol | sold | $533K | SEC ↗ |
| 2026-07-16 | Chief Executive Officer Kroeger Christopher A. | sold | $3K | SEC ↗ |
| 2026-07-16 | Chief Executive Officer Kroeger Christopher A. | sold | $1.0M | SEC ↗ |
| 2026-07-16 | Chief Executive Officer Kroeger Christopher A. | sold | $1.5M | SEC ↗ |
| 2026-07-16 | CAO and Interim CFO GILLIS JONATHAN | sold | $55K | SEC ↗ |
| 2026-07-16 | CAO and Interim CFO GILLIS JONATHAN | sold | $256K | SEC ↗ |
| 2026-07-16 | Chief Scientific Officer Lillie James Woodruff | sold | $456 | SEC ↗ |